OSAM
ALXN

O'Shaughnessy Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-886
Closed -$163K – 2935
2021
Q2 		$163K Sell
886
-166
-16% -$28.5K ﹤0.01% 1126
2021
Q1 		$161K Sell
1,052
-46
-4% -$7.12K ﹤0.01% 1017
2020
Q4 		$172K Buy
1,098
+753
+218% +$96.8K ﹤0.01% 883
2020
Q3 		$39K Buy
345
+39
+13% +$4.21K ﹤0.01% 1139
2020
Q2 		$34K Buy
306
+274
+856% +$29.1K ﹤0.01% 1070
2020
Q1 		$3K Buy
32
+18
+129% +$1.77K ﹤0.01% 1139
2019
Q4 		$2K Buy
+14
New +$1.5K ﹤0.01% 1698

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

O'Shaughnessy Asset Management's ALXN Position: Q3 2021 in Review

O'Shaughnessy Asset Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 886 shares — an estimated $163K sold.

O'Shaughnessy Asset Management first reported a position in ALXN in Q4 2019 and held it in 7 quarters. The position peaked at $172K in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • O'Shaughnessy Asset Management reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 886 Alexion Pharmaceuticals shares in Q3 2021, an estimated $163K.
  • O'Shaughnessy Asset Management first reported a position in Alexion Pharmaceuticals in Q4 2019 and held it in 7 quarters.
  • O'Shaughnessy Asset Management's Alexion Pharmaceuticals position peaked at $172K in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.